Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 14/20 | 0.61 |
| ▸ | ERBB2 | P04626 | 7/20 | 0.61 |
| ▸ | KDR | P35968 | 4/20 | 0.61 |
| ▸ | SRC | P12931 | 4/20 | 0.61 |
| ▸ | BRAF | P15056 | 2/20 | 0.61 |
| ▸ | CIT | O14578 | 2/20 | 0.61 |
| ▸ | GAK | O14976 | 2/20 | 0.61 |
| ▸ | EPHB6 | O15197 | 2/20 | 0.61 |
| ▸ | RIPK2 | O43353 | 2/20 | 0.61 |
| ▸ | STK17B | O94768 | 2/20 | 0.61 |
| ▸ | STK10 | O94804 | 2/20 | 0.61 |
| ▸ | ABL1 | P00519 | 2/20 | 0.61 |
| ▸ | LCK | P06239 | 2/20 | 0.61 |
| ▸ | LYN | P07948 | 2/20 | 0.61 |
| ▸ | RET | P07949 | 2/20 | 0.61 |
| ▸ | MET | P08581 | 2/20 | 0.61 |
| ▸ | HCK | P08631 | 2/20 | 0.61 |
| ▸ | FGR | P09769 | 2/20 | 0.61 |
| ▸ | KIT | P10721 | 2/20 | 0.61 |
| ▸ | EPHA1 | P21709 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7766288 | 0.92 | EGFR (0.73) | EGFRERBB2KDRSRCBRAF | |
| SCHEMBL31331907 | 0.86 | EGFR (0.65) | EGFRERBB2KDRSRCBRAF | |
| SCHEMBL1151056 | 0.84 | EGFR (0.82) | EGFRERBB2KDRSRCBRAF | |
| SCHEMBL8103000 | 0.84 | EGFR (0.65) | EGFRERBB2ERBB4MAPT | |
| SCHEMBL30416288 | 0.84 | EGFR (0.86) | EGFRERBB2KDRSRCBRAF | |
| SCHEMBL11304 | 0.84 | EGFR (0.86) | EGFRERBB2KDRSRCBRAF | |
| Hydrochloric Acid SCHEMBL15565027 | 0.84 | EGFR (0.81) | EGFRERBB2KDRSRCBRAF | |
| SCHEMBL7766270 | 0.83 | EGFR (0.72) | EGFRERBB2KDRSRCBRAF | |
| SCHEMBL7770429 | 0.82 | EGFR (0.72) | EGFRERBB2KDRSRCBRAF | |
| SCHEMBL12743373 | 0.81 | EGFR (0.68) | EGFRERBB2KDRSRCBRAF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0824525-B1 | QUINAZOLINE DERIVATIVES | ASTRAZENECA AB (SE) | 2001-06-13 | — | — | EP | claimed |
| US-5932574-A | ANTICANCER AGENT | ZENECA LIMITED (GB) | 1999-08-03 | — | — | US | claimed |
| EP-0824525-A1 | QUINAZOLINE DERIVATIVES | ZENECA LIMITED (GB) | 1998-02-25 | — | — | EP | claimed |
| WO-1996033977-A1 | QUINAZOLINE DERIVATIVES | ZENECA LIMITED (GB) | 1996-10-31 | — | — | WO | claimed |
| EP-0824525-B1 | QUINAZOLINE DERIVATIVES | ASTRAZENECA AB (SE) | 2001-06-13 | — | — | EP | disclosed |
| US-5932574-A | ANTICANCER AGENT | ZENECA LIMITED (GB) | 1999-08-03 | — | — | US | disclosed |
| EP-0824525-A1 | QUINAZOLINE DERIVATIVES | ZENECA LIMITED (GB) | 1998-02-25 | — | — | EP | disclosed |
| WO-1996033977-A1 | QUINAZOLINE DERIVATIVES | ZENECA LIMITED (GB) | 1996-10-31 | — | — | WO | disclosed |